Assessment of electroencephalography and event-related potentials in unresponsive patients with brain injury
Jian Wang,Xin Chen,Liang Zhou,Zi-yuan Liu,Yu-guo Xia,Jia You,Song Lan,Jin-fang Liu
DOI: https://doi.org/10.1016/j.neucli.2022.07.007
IF: 3.1
2022-01-01
Neurophysiologie Clinique
Abstract:Objective: To investigate the predictors of clinical outcomes in unresponsive patients with acquired brain injuries. Methods: Patients with coma or disorders of consciousness were enrolled from August 2019 to March 2021. A retrospective analysis of demographics, etiology, clinical score, diagnosis, electro-encephalography (EEG), and event-related potential (ERP) data from 1 week to 2 months after coma onset was conducted. Findings were assessed for predicting favorable outcomes at 6 months post-coma, and functional outcomes were determined using the Glasgow Outcome Scale-Extended (GOS-E). Results: Of 68 patients, 22 patients had a good neurological outcome at 6 months, while 11 died. Univariate analysis showed that motor response (Motor-R; p < 0.001), EEG pattern (p = 0.015), sleep spindles (p = 0.018), EEG reactivity (EEG-R; p < 0.001), mismatch negativity (MMN) amplitude at electrode Fz (FzMMNA; p = 0.001), P3a latency (p = 0.044), and P3a amplitude at electrode Cz (CzP3aA; p < 0.001) were significantly correlated with patient prognosis. Multivariable logistic regression analysis showed that FzMMNA, CzP3aA, EEG-R, and Motor-R were significant independent predictors of a favorable outcome. The sensitivity and specificity of FzMMNA (dichotomized at 1.16 mu V) were 86.4% and 58.5%, and of CzP3aA (cut-off value 2.76 mu V) were 90.9% and 70.7%, respectively. ERP amplitude (ERP-A), a combination of FzMMNA and CzP3aA, improved prediction accuracy, with an area under the receiver operating characteristic curve (AUC) of 0.884. A model incorporating Motor-R, EEG-R, and ERP-A yielded an outstanding predictive performance (AUC=0.921) for a favorable outcome. Conclusion: ERP-A and the prognostic model resulted in the efficient prediction of a favorable outcome in unresponsive patients. (C) 2022 Elsevier Masson SAS. All rights reserved.